Pulmonary Arterial Hypertension | Norton Healthcare

Indication: Pulmonary Arterial Hypertension

A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension

Sub-indication: Pulmonary Arterial Hypertension

Study Type: Drug Study

Principal Investigator: John McConnell, M.D.
Norton Pulmonary Specialists

Sponsor: Sponsor: Altavant Sciences, Inc.

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.